Professor
Department of Clinical Therapeutics, National and Kapodistrian University of Athens, School of Medicine, Athens, Greece, Greece
Evangelos Terpos, MD, PhD is a Professor of Hematology and Director of Stem Cell Transplantation Unit in the Department of Clinical Therapeutics of the National & Kapodistrian University of Athens, School of Medicine, Athens, Greece.
His main research interest is the biology of plasma cell dyscrasias and especially the biology and management of bone disease in multiple myeloma. Dr Terpos has evaluated the effect of bisphosphonates, denosumab and different anti-myeloma therapies on bone metabolism of myeloma patients. He has studied the role of modern imaging (DWI-MRI, PET-CT, etc) for diagnosis and follow-up of myeloma. He also works on the role of minimal residual disease (MRD) and circulating plasma cells in myeloma along with the biology and management of renal impairment in plasma cell neoplasms.
In the clinical research era, Dr Terpos participates in several clinical trials with novel agents in the myeloma field, including immunotherapies targeting BCMA. His research work was reported in more than 750 papers in peer-reviewed journals and Dr Terpos has more 40,000 citations and an h-index of 96 in ISI/Web of Knowledge and more than 60,000 citations and an h-index of 115 in Google Scholar.
Dr Terpos is a councilor of the European Hematology Association (EHA) board and member of the European Myeloma Network (EMN) board. He is co-chairing the Bone Sub-Committee of the International Myeloma Working Group and is a member of the Guideline Subgroup of the EMN. He is also a member of the Publication Committee of the International Myeloma Society (IMS).
He has given lectures at ASH, ASCO, EHA & EMN meetings as well as in International Myeloma Workshops. He is Associate Editor of Clinical Lymphoma Myeloma & Leukemia (official journal of IMS) and of the American Journal of Hematology for Myeloma.